Publication
Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.
Deborah Oluwaseun Babalola, Xiaoli Sun, Pengchao Deng, Shizhu Jin
In silico pharmacologyJan 1, 2026PMID 42798395doi:10.1007/s40203-026-00746-w PMC13612381Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
UNLABELLED: Patients with colon cancer can experience substantially different outcomes despite comparable anatomical stage, highlighting the need for molecular markers that complement conventional clinicopathological risk assessment. The interleukin-17 (IL-17) cytokine family has context-dependent…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Colon Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.